Publications by authors named "Lisbeth Enggaard"

Claim this Profile
C
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL.
Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, Christina Papangelou, Evangelia Minga, Lisbeth Enggaard

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of MRD-guided ibrutinib plus venetoclax in relapsed CLL: phase 2 VISION/HO141 trial.
Carsten U Niemann, Julie Dubois, Kazem Nasserinejad, Caspar da Cunha-Bang, Sabina Kersting, Lisbeth Enggaard

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Moritz Fürstenau, Arnon P Kater, Sandra Robrecht, Julia von Tresckow, Can Zhang, Lisbeth Enggaard

Lancet Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials.
Rebecca Svanberg Teglgaard, Hanne Vibeke Marquart, Hans Jakob Hartling, Jakob Thaning Bay, Caspar da Cunha-Bang, Lisbeth Enggaard

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia.
Noomi Vainer, Kathrine Aarup, Michael Asger Andersen, Lise Wind-Hansen, Tine Nielsen, Lisbeth Enggaard

Br J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Barbara Eichhorst, Carsten U Niemann, Arnon P Kater, Moritz Fürstenau, Julia von Tresckow, Lisbeth Enggaard

N Engl J Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV.
Uffe Klausen, Jacob Handlos Grauslund, Nicolai Grønne Dahlager Jørgensen, Shamaila Munir Ahmad, Merete Jonassen, Lisbeth Enggaard

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
Arnon P Kater, Mark-David Levin, Julie Dubois, Sabina Kersting, Lisbeth Enggaard

Lancet Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia.
Carsten U Niemann, Mark-David Levin, Julie Dubois, Sabina Kersting, Lisbeth Enggaard

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib.
Kathrine Aarup, Emelie Curovic Rotbain, Lisbeth Enggaard, Robert Schou Pedersen, Olav Jonas Bergmann

Eur J Haematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study.
Yasmin Ben-Dali, Mariam H Hleuhel, Caspar da Cunha-Bang, Christian Brieghel, Christian B Poulsen, Lisbeth Enggaard

Leuk Lymphoma· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial.
Margrethe Langer Bro, Christoffer Johansen, Peter Vuust, Lisbeth Enggaard, Bodil Himmelstrup

Support Care Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
Inger Lise Gade, Signe Juul Riddersholm, Ilse Christiansen, Annika Rewes, Mikael Frederiksen, Lisbeth Enggaard

Blood Adv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Danish National Chronic Lymphocytic Leukemia Registry.
Caspar da Cunha-Bang, Christian Hartmann Geisler, Lisbeth Enggaard, Christian Bjørn Poulsen, Peter de Nully Brown

Clin Epidemiol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis